Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 36% ± 16% | |
| GABAergic neuron | 3 studies | 33% ± 16% |
Insufficient scRNA-seq data for expression of SYT3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 1584.70 | 2535 / 2642 | 98% | 8.91 | 691 / 705 |
| adrenal gland | 14% | 27.05 | 37 / 258 | 73% | 6.43 | 167 / 230 |
| eye | 0% | 0 | 0 / 0 | 50% | 1.58 | 40 / 80 |
| prostate | 14% | 59.09 | 35 / 245 | 35% | 2.77 | 174 / 502 |
| kidney | 9% | 13.58 | 8 / 89 | 21% | 0.88 | 192 / 901 |
| ovary | 0% | 0 | 0 / 180 | 29% | 0.73 | 126 / 430 |
| lung | 4% | 6.06 | 23 / 578 | 19% | 0.57 | 217 / 1155 |
| thymus | 10% | 17.94 | 68 / 653 | 11% | 0.28 | 69 / 605 |
| skin | 0% | 0.27 | 2 / 1809 | 21% | 0.67 | 97 / 472 |
| pancreas | 2% | 3.35 | 6 / 328 | 18% | 0.58 | 32 / 178 |
| liver | 0% | 0 | 0 / 226 | 15% | 1.73 | 61 / 406 |
| breast | 3% | 4.47 | 13 / 459 | 11% | 0.26 | 128 / 1118 |
| esophagus | 0% | 0.44 | 5 / 1445 | 14% | 0.36 | 25 / 183 |
| uterus | 1% | 1.75 | 2 / 170 | 8% | 0.36 | 36 / 459 |
| stomach | 0% | 0.34 | 1 / 359 | 8% | 0.29 | 24 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
| intestine | 2% | 2.92 | 20 / 966 | 5% | 0.12 | 25 / 527 |
| bladder | 0% | 0 | 0 / 21 | 6% | 0.24 | 28 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
| blood vessel | 0% | 0.40 | 4 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0017156 | Biological process | calcium-ion regulated exocytosis |
| GO_1903861 | Biological process | positive regulation of dendrite extension |
| GO_0030154 | Biological process | cell differentiation |
| GO_0070382 | Cellular component | exocytic vesicle |
| GO_0030658 | Cellular component | transport vesicle membrane |
| GO_0005768 | Cellular component | endosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0000149 | Molecular function | SNARE binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
| GO_0001786 | Molecular function | phosphatidylserine binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SYT3 |
| Protein name | Synaptotagmin-3 (Synaptotagmin III) (SytIII) Synaptotagmin 3 |
| Synonyms | |
| Description | FUNCTION: Ca(2+) sensor involved in Ca(2+)-dependent exocytosis of secretory vesicles through Ca(2+) and phospholipid binding to the C2 domain. Ca(2+) induces binding of the C2-domains to phospholipid membranes and to assembled SNARE-complexes; both actions contribute to triggering exocytosis (By similarity). Plays a role in dendrite formation by melanocytes . . |
| Accessions | M0QYH4 M0QY70 ENST00000338916.8 ENST00000595557.1 Q9BQG1 ENST00000598997.1 ENST00000600079.6 ENST00000593901.5 |